Su.16. Phenotypic Characteristics of Monocyte-derived Dendritic Cells in Acute Hepatitis B and Acute Hepatitis C

2008 ◽  
Vol 127 ◽  
pp. S129
Author(s):  
Leonid Titov ◽  
Andrei Hancharou ◽  
Lawrence DuBuske
Keyword(s):  
Dendritic Cells ◽  
Hepatitis C ◽  
Hepatitis B ◽  
Acute Hepatitis ◽  
Acute Hepatitis C ◽  
Phenotypic Characteristics ◽  
Acute Hepatitis B

scholarly journals Trends in the Acute Hepatitis B and Acute Hepatitis C in Bulgaria

Folia Medica ◽  
2019 ◽  
Vol 61 (2) ◽  
pp. 197-203
Author(s):  
Magdalena P. Baymakova ◽  
Milena Karcheva
Keyword(s):  
European Union ◽  
Hepatitis C ◽  
Hepatitis B ◽  
Acute Hepatitis ◽  
Acute Hepatitis C ◽  
The European Union ◽  
Acute Hepatitis B ◽  
Before And After ◽  
Acute Hcv ◽  
The Eu

Abstract Introduction: Bulgaria joined European Union (EU) on 1 January 2007. Since the accession all regulations, directives, decisions, recommendations, and opinions of the European Parliament, the Council of the European Union, and the European Commission are being implemented. Aim: The purpose of this study was to present the morbidity of acute hepatitis B virus (HBV) and acute hepatitis C virus (HCV) in Bulgaria before and after accession to the EU. Materials and methods: A retrospective study was performed. The morbidity of acute HBV and acute HCV infections in Bulgaria was analyzed over a period of sixteen years (2000−2016). The collected data were based on the National Center of Infectious and Parasitic Diseases (NCIPD) and the National Center of Public Health and Analyses (NCPHA). Results: Between 2000 and 2016, 11038 cases of acute HBV infection and 1681 cases of acute HCV infection were reported in Bulgaria. Before the accession to EU, the morbidity rates of acute HBV and acute HCV infections were 12.77 cases per 100 000 population (95% CI: 11.45–13.97) and 1.52 cases per 100 000 population (95% CI: 1.17–1.96), respectively. After the accession to the EU, the morbidity rates of acute HBV and acute HCV infections were 5.29 cases per 100 000 population (95% CI: 3.86–6.73) and 1.14 cases per 100 000 population, respectively. Conclusion: Analysis of the data suggests that there is a tendency for lower morbidity rates of acute HBV. The situation with acute HCV is relatively stable over the years regardless of EU membership.

scholarly journals Enhanced Surveillance of Acute Hepatitis B and C in Four Health Regions in Canada, 1998 TO 1999

2001 ◽  
Vol 12 (6) ◽  
pp. 357-363 ◽  
Author(s):  
Shimian Zou ◽  
Jun Zhang ◽  
Martin Tepper ◽  
Antonio Giulivi ◽  
Beverley Baptiste ◽  
...  
Keyword(s):  
Risk Factors ◽  
Risk Factor ◽  
Hepatitis C ◽  
Drug Use ◽  
Hepatitis B ◽  
Acute Hepatitis ◽  
Injection Drug Use ◽  
Injection Drug ◽  
Acute Hepatitis C ◽  
Acute Hepatitis B

OBJECTIVE:To assess the incidence and risk factors for acute hepatitis B and acute hepatitis C in a defined Canadian population.PATIENTS AND METHODS:An enhanced surveillance system was established in October 1998 to identify cases of acute hepatitis B and C infections in four regions in Canada, with a total population of approximately 3.2 million people. Information on demographic and clinical characteristics, laboratory results and potential risk factors was collected using predefined questionnaires.RESULTS:A total of 79 cases of acute hepatitis B and 102 cases of acute hepatitis C were identified from October 1998 to December 1999, resulting in an incidence rate of 2.3 and 2.9/100,000 person-years, respectively. Males had higher incidence rates than females. The incidence of acute hepatitis B peaked at age 30 to 39 years for both males and females, whereas acute hepatitis C peaked at 30 to 39 years for males and 15 to 29 years for females. At least 34% of acute hepatitis B and 63% of acute hepatitis C were associated with injection drug use. Persons who were 15 to 39 years of age were more likely to report injection drug use as a risk factor. Heterosexual contact was reported to be a risk factor for 36.6% of acute hepatitis B cases and 3.5% of acute hepatitis C cases.CONCLUSIONS:The surveillance provides national incidence estimates of clinically recognized acute hepatitis B and C. Both hepatitis B and C are important public health threats to Canadians. Prevention efforts for both diseases should focus on injection drug use, especially for people aged 15 to 39 years. Risky sexual behaviour is also a major concern in prevention of hepatitis B in Canada.

scholarly journals Acute viral hepatitis prevalence in the last five years at „Sf. Cuv. Parascheva“ Infectious Diseases Clinical Hospital, Galati

2015 ◽  
Vol 18 (2-3) ◽  
pp. 99-102
Author(s):  
Miruna Drăgănescu ◽  
◽  
Alina Iancu ◽  
◽  
◽  
...  
Keyword(s):  
Hepatitis C ◽  
Hepatitis B ◽  
Infectious Diseases ◽  
Acute Hepatitis ◽  
Viral Hepatitis ◽  
Acute Viral Hepatitis ◽  
Acute Hepatitis C ◽  
Clinical Hospital ◽  
Acute Hepatitis B ◽  
National Trends

Introduction. Acute viral hepatitis is a major pathology under national and international surveillance due to both lethal or chronic evolution. Objectives. To evaluate the prevalence of acute viral hepatitis in the last five years in Galati. Methods. Retrospective study based on patients dossiers addmited for acute viral hepatitis between 01.01.2010-31.12.2014 in Infectious Diseases Clinical Hospital from Galati. Results. The decreasing prevalence of acute hepatitis of 1.7 times was based on reduction of acute hepatitis B cases; the year 2013 has shown an epidemic increase of acute hepatitis A cases, similar to the national data. Acute hepatitis C had the same prevalence over the years. For 1/3 of cases no A, B, C etiology was found. Correlation (p < 0.0001) between etiology and patients age was found. Acute hepatitis B has shown the most severe cases due to jaundice and citolysis intensity. No differences between gender was found but the illness was more frequent in urban area. Conclusions. Our study has shown the decreasing hepatitis B prevalence while hepatitis C had the similar prevalence, as the national trends.

Historical study of acute hepatitis B in subjects with or without hepatitis C infection

2012 ◽  
Vol 23 (6) ◽  
pp. e146-e149 ◽  
Author(s):  
Tommaso Stroffolini ◽  
Maria Rapicetta ◽  
Flavia Lombardo ◽  
Paola Chionne ◽  
Elisabetta Madonna ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Hepatitis B ◽  
Acute Hepatitis ◽  
Historical Study ◽  
Hepatitis C Infection ◽  
Acute Hepatitis B

Simultaneously acute hepatitis B virus and C virus coinfection and subsequent chronic hepatitis C

2007 ◽  
Vol 39 (4) ◽  
pp. 351-354 ◽  
Author(s):  
Shuo-Wei Chen ◽  
Tsung-Shih Lee ◽  
Ching-Chih Hu ◽  
Liang-Che Chang ◽  
Rong-Nan Chien
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Acute Hepatitis ◽  
Chronic Hepatitis C ◽  
B Virus ◽  
Acute Hepatitis B

Acute hepatitis B in a patient with OLT during treatment with peg-interferon and ribavirin for hepatitis C recurrence

2012 ◽  
Vol 24 (6) ◽  
pp. 369-372
Author(s):  
Elisa Biliotti ◽  
Sabu Zacharia ◽  
Stefania Grieco ◽  
Martina Spaziante ◽  
Michela Giusto ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Hepatitis B ◽  
Acute Hepatitis ◽  
Acute Hepatitis B ◽  
Hepatitis C Recurrence

scholarly journals Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection.

BMJ ◽  
1993 ◽  
Vol 307 (6912) ◽  
pp. 1095-1097 ◽  
Author(s):  
L T Mimms ◽  
J W Mosley ◽  
F B Hollinger ◽  
R D Aach ◽  
C E Stevens ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Hepatitis B Virus ◽  
Virus Infection ◽  
Hepatitis B ◽  
Acute Hepatitis ◽  
Acute Infection ◽  
Hepatitis B Virus Infection ◽  
B Virus ◽  
Acute Hepatitis B

Sustained remission of chronic hepatitis C after acute hepatitis B superinfection

2006 ◽  
Vol 38 (9) ◽  
pp. 818-821 ◽  
Author(s):  
Wolfgang Jessner ◽  
Michael Strasser ◽  
Ivo Graziadei ◽  
Frieder Berr ◽  
Wolfgang Vogel
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Hepatitis B ◽  
Acute Hepatitis ◽  
Chronic Hepatitis C ◽  
Sustained Remission ◽  
Acute Hepatitis B
Sign in / Sign up

Export Citation Format

Share Document